
$88.910
-7.557 (-8.50%)At close
- High
- 92.560
- Open
- 89.860
- VWAP
- 88.17
- Volume
- 400.46M
- Mkt Cap
- —
- Low
- 83.050
- Amount
- 35.31B
- EV/EBITDA, TTM
- -89.42
Anthropic, PBC develops and maintains advanced artificial intelligence (AI) models in the United States and internationally. The company's Claude Platform lets developers and businesses build, manage, and deploy agentic AI applications on infrastructure. Its direct applications and integrations include Claude Code, a coding agent that handles multi-step software development tasks; Claude Cowork, a work agent that has computer-use capability and enables it to work with professionals on end-to-end business tasks; Claude.ai, a conversational product for enterprises, teams, and individuals; Claude Security, a defensive cybersecurity product; Claude Duet, a proactive agent that monitors connected applications, provide daily briefings, perform tasks, and builds web applications while operating on a cloud-based virtual machine; Claude Tag, a collaborative agent that works alongside teams in productivity tools; Claude Design, which enables users to create polished designs, prototypes, presentations, and other visual work through natural language conversation and direct editing; and Claude Science, an AI workbench for scientific research that brings literature analysis, data processing, and manuscript preparation into a single desktop environment. The company serves financial services, healthcare, life sciences, law, and education industries. Anthropic, PBC was incorporated in 2021 and is based in San Francisco, California. Anthropic, PBC is a subsidiary of Anthropic Founders, LLC.
AI analysis of Anthropic, PBC Class A Common Stock (ANT)
HoldAnthropic is not a good buy right now due to its recent volatility and negative sentiment in the AI market. The stock has dropped 8.50% in the last trading session and is currently priced at $88.91, which is significantly below its 52-week high of $115.10. Additionally, the company reported a gross margin of 52.11% in Q4 2025, but its net income remains deeply negative, indicating profitability concerns.
Valuation Metrics
Events Timeline
News
- 8.511-21Fool
Anthropic's IPO Leaves It with $250 Billion Cash Reserve
- 8.511-22Fool
Anthropic Sets Record with $81 Billion IPO
- 8.511-21Fool
Comparative Analysis of SpaceX and Anthropic IPOs
- 8.511-21Fool
On Semiconductor: The Preferred AI Investment
4.511-21CNBCMarket Faces Severe Decline Amid AI Trade Concerns
ANT FAQ — answered by Alphio AI
Anthropic, PBC develops and maintains advanced artificial intelligence (AI) models in the United States and internationally. The company's Claude Platform lets developers and businesses build, manage, and deploy agentic AI applications on infrastructure. Its direct applications and integrations include Claude Code, a coding agent that handles multi-step software development tasks; Claude Cowork, a work agent that has computer-use capability and enables it to work with professionals on end-to-end business tasks; Claude.ai, a conversational product for enterprises, teams, and individuals; Claude Security, a defensive cybersecurity product; Claude Duet, a proactive agent that monitors connected applications, provide daily briefings, perform tasks, and builds web applications while operating on a cloud-based virtual machine; Claude Tag, a collaborative agent that works alongside teams in productivity tools; Claude Design, which enables users to create polished designs, prototypes, presentations, and other visual work through natural language conversation and direct editing; and Claude Science, an AI workbench for scientific research that brings literature analysis, data processing, and manuscript preparation into a single desktop environment. The company serves financial services, healthcare, life sciences, law, and education industries. Anthropic, PBC was incorporated in 2021 and is based in San Francisco, California. Anthropic, PBC is a subsidiary of Anthropic Founders, LLC. It operates in the Technology sector.
Anthropic is not a good buy right now due to its recent volatility and negative sentiment in the AI market. The stock has dropped 8.50% in the last trading session and is currently priced at $88.91, which is significantly below its 52-week high of $115.10. Additionally, the company reported a gross margin of 52.11% in Q4 2025, but its net income remains deeply negative, indicating profitability concerns.
Community
More ↗

#GateDirectIPOPhase3ANTAllocates92100Shares Gate ANT IPO subscription — allocation is complete, and the next phase is price discovery. The allocation results are confirmed, but the real focus has now shifted from subscription demand to market price discovery. Gate Phase 3 Anthropic (ANT) IPO subscription allocated a total of 92,100 shares, with total subscription demand reaching 152 million USDT at an issue price of 83 USDT per share. This round was heavily oversubscribed, but the allocation rate was only about 5.03%, meaning subscribers actually received far fewer shares than they applied for. What matters most now? IPO Cross is the next key phase. It will determine the opening price based on actual buy and sell orders, rather than relying solely on the 83 USDT issue price. * Above 83 USDT: strong demand indicates buyers are willing to pay a premium. * Near 83 USDT: the market recognizes the issue price as a reasonable starting point. * Below 83 USDT: early selling pressure may indicate that subscription enthusiasm exceeded actual market demand. Since there is no lock-up period, allocated shares can be sold immediately after distribution. This provides flexibility but also creates the risk of heavy early selling. Valuation question With an estimated implied valuation close to 1 trillion USD, Anthropic is already in a very high valuation range. Its AI growth story may be attractive, but market expectations are already quite high. At this level, even with strong fundamentals, an overly aggressive opening valuation may not guarantee upside. The precedent from the SpaceX IPO subscription is also worth remembering: high visibility and strong initial demand do not guarantee that the market price will remain above the issue price. My view: getting an allocation is good in terms of gaining participation, but it does not necessarily mean returns are assured. The final matching price in IPO Cross will be the first real signal of market demand for the 83 USDT price. I will avoid making decisions based solely on oversubscription data, and instead watch the opening price, liquidity, and early selling pressure before deciding whether to continue holding or take profits.
Show more#GateDirectIPO Phase 3 brings another major update to the community, with ANT allocated 92,100 shares in the latest phase. This allocation reflects continued market interest in the ANT IPO and marks another notable milestone for participants to watch. With Phase 3 in focus, traders and investors are closely following the allocation details and what may come next for ANT. This development also draws more attention to the Gate Direct IPO mechanism, with community participation and allocation results remaining key points of interest. 📌 Key updates: • Phase 3 allocation results announced • ANT: allocated 92,100 shares • Investors are closely watching follow-up developments • ANT remains a focus of attention in the crypto community The latest allocation results may become an important part of ANT's overall market story. As the IPO process moves forward, subsequent updates may further reveal participation, demand, and future trading activity. What do you think of ANT's latest allocation results—is this a positive development, or just another step in the IPO process? #GateDirectIPOPhase3ANTAllocates92100Shares
Show more
Hmm? I've been using Claude for almost a week now, so why hasn't my account been banned yet? Didn't they say Anthropic makes over $2.7 billion in profit from banning Chinese accounts? I think it makes sense to keep shorting $ANT. Around $60 seems about right 👀
Show more
Related articles
- How to Buy the Dip in the 2026 Stock Market Correction Without Guessing the BottomHow to buy the dip in the November 2026 stock market correction: what history says, why a hiking Fed changes the math, and how to stage purchases safely.
- Required Minimum Distributions in a Down Market: How to Take Your 2026 RMD Without Selling LowHow to take required minimum distributions in a down market in 2026: what to sell, in-kind RMDs, QCDs, the Dec. 31 deadline, penalties, and tax moves to use.
- PCE Inflation Report and the Stock Market: What the Fed's Preferred Gauge Means in a CorrectionThe PCE inflation report lands Nov 25 amid a stock correction and Fed hike talk. Learn PCE vs CPI, what to watch, and how stocks, sectors and bonds react.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.


